Table 4 of Dratviman-Storobinsky, Mol Vis 2009; 15:2326-2338. Table 4 of Dratviman-Storobinsky, Mol Vis 2009; 15:2326-2338.
Table 4. Gene expression in the untreated and bevacizumab-treated corneas.
| Time point Gene |
2 days | 8 days | 10 days | 14 days | ||||
|---|---|---|---|---|---|---|---|---|
| Model | Treated | Model | Treated | Model | Treated | Model | Treated | |
| VEGF | 2.98 (±0.04) | 2.49 (±1.95) | 3.80 (±5.50) | 2.96 (±2.78) | 4.10 (±3.30) | 3.27 (±2.32) | 3.64 (±2.41) | 3.43 (±1.71) |
| PEDF | 0.35 (±0.48) | 0.44 (±0.09) | 0.65 (±0.19) | 2.0 (±0.7) | 0.84 (±0.08) | 1.78 (±0.78) | 3.54 (±0.37) | 5.48 (±3.97) |
| IGF-1 | 1.65 (±1.65) | 0.66 (±0.45) | 0.90 (±0.31) | 3.60 (±1.76) | 1.37 (±0.85) | 5.41 (±4.96) | 2.88 (±0.68) | 1.94 (±0.89) |
| MIP-2 | 166.43 | 332.53 | 75.25 | 197.11 | 76.25 | 170.83 | 11.45 | 4.63 |